Dr. Moro, I am very interested in the imaging capabilities of Recaf.

We have seen a few of the images from mice and humans with the use of Recaf. I hope that I am not oversimplifying this but could't trials for imaging be set up in animals / humans relatively easy. This technology would be a no brainer if a company could package a highly specific and sensitive wide spectrum marker with imaging. Have we approached a large company such as GE or Siemens to license the imaging to?

"Our technology can locate the tumor in the body using present hospital equipment. Preliminary results have been attained in humans." After clicking the link, go to slide #16
http://www.biocurex.com/pages/PowerP...

Recaf is not just a wide spectrum cancer marker. It also attaches itself to the cancer in the body and can be identified / imaged.

My understanding is that Goshen has been working on imaging but one would think that Recaf with the imaging capability would trump all others. Even if we didn't take the next step to send a cancer killer with the Recaf, atleast cancer could be diagnosed and verified with regard to its location. This would be a large step for mankind.

1.Test for cancer regardless of type or location with a great sensitivity / specificity.
2. Locate the cancer via imaging with standard present hospital equipment.

Why would anyone want to use any other specific marker at this point? The specific markers would fall to the way side.